Durisala Desaiah, PhD

Article

Suicidal Thoughts and Reasons for Living in Hospitalized Patients With Severe Depression: Post-Hoc Analyses of a Double-Blind Randomized Trial of Duloxetine

June 15, 2014

Around 15% of patients with major depressive disorder acknowledge having made a suicide attempt. This post hoc analysis of the data from a previously published study was conducted to...

Koen Demyttenaere, Durisala Desaiah, Joel Raskin, et al

Article

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials

December 15, 2011

Read this meta-analysis of studies examining the efficacy of duloxetine for both painful physical symptoms and depressive illness in patients with mild to moderate major depressive disorder.

Susan G. Ball, Durisala Desaiah, Melissa E. Spann, et al

Original Research

Efficacy and Safety of Duloxetine 60 mg and 120 mg Daily in Patients Hospitalized for Severe Depression: A Double-Blind Randomized Trial

September 21, 2010

Stephan Brecht, Durisala Desaiah, Elisete S. Marechal, et al

Original Research

Patient-Assessed Versus Physician-Assessed Disease Severity and Outcome in Patients With Nonspecific Pain Associated With Major Depressive Disorder

February 16, 2009

Koen Demyttenaere, Durisala Desaiah, Claude Petit, et al

Original Research

The Significance of Treating Somatic Symptoms on Functional Outcome Improvement in Patients With Major Depressive Disorder: A Post Hoc Analysis of 2 Trials

August 15, 2008

Thomas N. Wise, Adam L. Meyers, Durisala Desaiah, et al

Original Research

Switching to Duloxetine From Selective Serotonin Reuptake Inhibitor Antidepressants: A Multicenter Trial Comparing 2 Switching Techniques

January 15, 2008

David G. S. Perahia, Deborah Quail, Durisala Desaiah, et al

Original Research

Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial

November 15, 2007

Stephan Brecht, Christine Courtecuisse, Catherine Debieuvre, et al

Commentary

Duloxetine in Practice-Based Clinical Settings: Assessing Effects on the Emotional and Physical Symptoms of Depression in an Open-Label, Multicenter Study

August 15, 2007

Madelaine M. Wohlreich, Curtis G. Wiltse, Durisala Desaiah, et al

Suicidal Thoughts and Reasons for Living in Hospitalized Patients With Severe Depression: Post-Hoc Analyses of a Double-Blind Randomized Trial of Duloxetine

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials

Efficacy and Safety of Duloxetine 60 mg and 120 mg Daily in Patients Hospitalized for Severe Depression: A Double-Blind Randomized Trial

Patient-Assessed Versus Physician-Assessed Disease Severity and Outcome in Patients With Nonspecific Pain Associated With Major Depressive Disorder

The Significance of Treating Somatic Symptoms on Functional Outcome Improvement in Patients With Major Depressive Disorder: A Post Hoc Analysis of 2 Trials

Switching to Duloxetine From Selective Serotonin Reuptake Inhibitor Antidepressants: A Multicenter Trial Comparing 2 Switching Techniques

Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial

Duloxetine in Practice-Based Clinical Settings: Assessing Effects on the Emotional and Physical Symptoms of Depression in an Open-Label, Multicenter Study

ELSEWHERE:

FOLLOW US:

Durisala Desaiah, PhD

Suicidal Thoughts and Reasons for Living in Hospitalized Patients With Severe Depression: Post-Hoc Analyses of a Double-Blind Randomized Trial of Duloxetine

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials

Efficacy and Safety of Duloxetine 60 mg and 120 mg Daily in Patients Hospitalized for Severe Depression: A Double-Blind Randomized Trial

Patient-Assessed Versus Physician-Assessed Disease Severity and Outcome in Patients With Nonspecific Pain Associated With Major Depressive Disorder

The Significance of Treating Somatic Symptoms on Functional Outcome Improvement in Patients With Major Depressive Disorder: A Post Hoc Analysis of 2 Trials

Switching to Duloxetine From Selective Serotonin Reuptake Inhibitor Antidepressants: A Multicenter Trial Comparing 2 Switching Techniques

Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial

Duloxetine in Practice-Based Clinical Settings: Assessing Effects on the Emotional and Physical Symptoms of Depression in an Open-Label, Multicenter Study

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles